Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
In its first test, the 30-kilowatt military laser burned through a truck's engine in a matter of seconds.
Islamic State militants have begun to raze ancient ruins at the site of the Assyrian city of Nimrud.
The mother of a boy excluded from taking part in World Book Day when he dressed as Christian Grey has insisted the outfit was his idea.